StrokeDx is pioneering a transformative approach to stroke detection through the development of a portable neuroimaging device that significantly reduces the time-to-treatment for stroke patients. Recognizing that every minute counts in stroke care, the company’s technology continuously monitors blood flow in the brain, identifying areas of abnormal blood flow that can indicate ischemic or hemorrhagic strokes. This innovative method allows for rapid triage and detection, contrasting sharply with traditional imaging techniques like CT and MRI, which are costly, bulky, and time-consuming. By providing a low-cost, handheld solution, StrokeDx aims to enhance accessibility and efficiency in stroke care, ultimately improving patient outcomes.

The company has garnered recognition for its groundbreaking technology, winning the 2023 MedTech Innovator Global Competition and receiving the Vision Award at the WSGR Medical Device & Digital Health Conference. These accolades highlight StrokeDx's commitment to revolutionizing stroke detection and care. With a recent oversubscribed seed funding round of $5 million, the company is well-positioned to advance its next-generation stroke technology. By collaborating with industry leaders and leveraging resources from the MedTech Innovator network, StrokeDx is poised to refine its product and expand its impact in the medical field, striving to make significant strides in the fight against stroke.

United States

StrokeDx provides portable, rapid, and non-invasive stroke diagnostic and imaging tools.

StrokeDx

Company Details